Related Experiment Videos
[Cervical adenocarcinoma: histologic staging and pelvic lymph node metastasis]
Gan No Rinsho. Japan Journal of Cancer Clinics
|February 1, 1984
Summary
Stage Ia cervical adenocarcinoma, characterized by early gland budding, shows no pelvic lymph node metastasis. This finding suggests Stage Ia may be managed similarly to adenocarcinoma in situ (AIS).
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Cancer Staging
Context:
- Cervical adenocarcinoma staging is crucial for treatment decisions.
- Distinguishing early-stage disease from invasive cancer impacts patient management.
- Pelvic lymph node metastasis is a key prognostic factor in cervical cancer.
Purpose:
- To investigate the correlation between histologic stage of cervical adenocarcinoma and pelvic lymph node metastasis.
- To determine if Stage Ia adenocarcinoma, defined by specific glandular budding criteria, exhibits lymph node involvement.
Summary:
- A study of 138 patients undergoing hysterectomy analyzed the relationship between cervical adenocarcinoma histology and lymph node metastasis.
- Pelvic lymph node metastases were absent in Stage Ia adenocarcinoma (AIS with glandular or solid cancer budding into stroma).
- Metastases were present in Stage Ib-III adenocarcinoma, supporting distinct management for Stage Ia.
Impact:
- Findings suggest Stage Ia cervical adenocarcinoma could potentially be treated with less aggressive protocols, similar to adenocarcinoma in situ (AIS).
- This could lead to de-escalation of treatment for a subset of early-stage cervical cancer patients.
- Refined understanding of early cervical adenocarcinoma invasiveness and metastatic potential.